Metabolic effects of a growth hormone-releasing factor in patients with HIV.

@article{Falutz2007MetabolicEO,
  title={Metabolic effects of a growth hormone-releasing factor in patients with HIV.},
  author={J. Falutz and S. Allas and K. Blot and D. Potvin and D. Kotler and M. Somero and D. Berger and S. Brown and G. Richmond and J. Fessel and Ralph Turner and S. Grinspoon},
  journal={The New England journal of medicine},
  year={2007},
  volume={357 23},
  pages={
          2359-70
        }
}
BACKGROUND Visceral adipose tissue accumulates during antiretroviral therapy in many patients who are infected with the human immunodeficiency virus (HIV); this process is associated with an increased cardiovascular risk. We assessed the use of a growth hormone-releasing factor analogue, tesamorelin, to decrease visceral adiposity. METHODS We randomly assigned 412 patients with HIV (86% of whom were men) who had an accumulation of abdominal fat to receive a daily subcutaneous injection of… Expand
161 Citations
Does low-dose growth hormone therapy improve the body composition of patients infected with HIV?
  • 1
Management of Fat Accumulation in Patients with HIV Infection
  • J. Falutz
  • Biology, Medicine
  • Current HIV/AIDS reports
  • 2011
  • 16
A characterisation of low-grade inflammation and metabolic complications in HIV-infected patients.
  • 4
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
  • T. Stanley, J. Falutz, +6 authors S. Grinspoon
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
  • 17
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 46 REFERENCES
Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected Patients
  • 101
Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting
  • 269
Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy
  • 137
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
  • C. Hadigan, J. Meigs, +9 authors S. Grinspoon
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2001
  • 672
  • PDF
...
1
2
3
4
5
...